These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8800881)

  • 1. The symptom questionnaire for benign prostatic hyperplasia: an ambiguous indicator for an ambiguous disease.
    Stoevelaar HJ; van de Beek C; Nijs HG; Casparie AF; McDonnell J; Janknegt RA
    Br J Urol; 1996 Feb; 77(2):181-5. PubMed ID: 8800881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.
    Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK; Cockett AT
    J Urol; 1992 Nov; 148(5):1549-57; discussion 1564. PubMed ID: 1279218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.
    Yalla SV; Sullivan MP; Lecamwasam HS; DuBeau CE; Vickers MA; Cravalho EG
    J Urol; 1995 Mar; 153(3 Pt 1):674-9; discussion 679-80. PubMed ID: 7532231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.
    Chancellor MB; Rivas DA; Keeley FX; Lotfi MA; Gomella LG
    Br J Urol; 1994 Aug; 74(2):200-3. PubMed ID: 7522872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia.
    Liu CC; Wang CJ; Huang SP; Chou YH; Wu WJ; Huang CH
    Kaohsiung J Med Sci; 2004 Jun; 20(6):273-8. PubMed ID: 15253468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia.
    Barry MJ; Fowler FJ; O'leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK; Cockett AT;
    J Urol; 2017 Feb; 197(2S):S189-S197. PubMed ID: 28012747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    McVary KT; Rademaker A; Lloyd GL; Gann P
    J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sociodemographic and health status variables on the American Urological Association symptom scores in patients with lower urinary tract symptoms.
    Badia X; Rodríguez F; Carballido J; García Losa M; Unda M; Dal-Ré R; Roset M;
    Urology; 2001 Jan; 57(1):71-7. PubMed ID: 11164147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?
    Barry MJ; Williford WO; Chang Y; Machi M; Jones KM; Walker-Corkery E; Lepor H
    J Urol; 1995 Nov; 154(5):1770-4. PubMed ID: 7563343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials.
    Roehrborn CG; Malice M; Cook TJ; Girman CJ
    Urology; 2001 Aug; 58(2):210-6. PubMed ID: 11489703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia.
    Kurita Y; Masuda H; Terada H; Suzuki K; Fujita K
    Urology; 1998 Apr; 51(4):595-600. PubMed ID: 9586613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association.
    Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK
    J Urol; 1992 Nov; 148(5):1558-63; discussion 1564. PubMed ID: 1279219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire.
    Donovan JL; Abrams P; Peters TJ; Kay HE; Reynard J; Chapple C; De La Rosette JJ; Kondo A
    Br J Urol; 1996 Apr; 77(4):554-62. PubMed ID: 8777617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status.
    Blanker MH; Groeneveld FP; Prins A; Bernsen RM; Bohnen AM; Bosch JL
    BJU Int; 2000 Apr; 85(6):665-71. PubMed ID: 10759662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association.
    Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK
    Med Care; 1995 Apr; 33(4 Suppl):AS145-55. PubMed ID: 7536866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography.
    Ukimura O; Kojima M; Inui E; Ochiai A; Hata Y; Watanabe M; Saitoh M; Watanabe H
    J Urol; 1996 Nov; 156(5):1673-8. PubMed ID: 8863568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.